KCM
ATYR

Kalehua Capital Management’s aTyr Pharma ATYR Stock Holding History

Kalehua Capital Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
+1,788,167
New +$1.17M 0.76% 21

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kalehua Capital Management's ATYR Position: Q2 2026 in Review

Kalehua Capital Management opened a new position in aTyr Pharma (ATYR) in Q2 2026: 1,788,167 shares worth $1.07M. The stake represents 0.76% of the portfolio and ranks #21 among its holdings.

86 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Kalehua Capital Management held 1,788,167 shares of aTyr Pharma worth $1.07M as of Q2 2026.
  • aTyr Pharma was a new Kalehua Capital Management position in Q2 2026.
  • aTyr Pharma made up 0.76% of Kalehua Capital Management's portfolio in Q2 2026, its #21 holding.
  • 86 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Kalehua Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.